載入...
ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker
Novel action beta‐blockers combine many different pharmacological effects. The espindolol exhibits effects through β and central 5‐HT1α receptors to demonstrate pro‐anabolic, anti‐catabolic, and appetite‐stimulating actions. In the ACT‐ONE trial, espindolol reversed weight loss and improved handgrip...
Na minha lista:
| 發表在: | J Cachexia Sarcopenia Muscle |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5011815/ https://ncbi.nlm.nih.gov/pubmed/27625919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12136 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|